Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 9281519, 17 pages
https://doi.org/10.1155/2017/9281519
Research Article

Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome

1Department of Cell Signaling, Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia
2Department of Biology and Pathology of Domestic, Laboratory and Exotic Animals, Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow 109472, Russia
3Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow 119991, Russia

Correspondence should be addressed to Evgeni Yu. Zernii; ur.usm.yksrezoleb@inrez and Ivan I. Senin; ur.usm.yksrezoleb@nines

Received 29 May 2017; Accepted 14 August 2017; Published 12 October 2017

Academic Editor: Deborah A. Ferrington

Copyright © 2017 Evgeni Yu. Zernii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007),” The Ocular Surface, vol. 5, no. 2, pp. 75–92, 2007. View at Publisher · View at Google Scholar
  2. R. G. Fiscella, “Understanding dry eye disease: a managed care perspective,” The American Journal of Managed Care, vol. 17, Supplement 16, pp. S432–S439, 2011. View at Google Scholar
  3. “The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007),” The Ocular Surface, vol. 5, no. 2, pp. 93–107, 2007. View at Publisher · View at Google Scholar
  4. A. Yagci and C. Gurdal, “The role and treatment of inflammation in dry eye disease,” International Ophthalmology, vol. 34, no. 6, pp. 1291–1301, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Malafa, J. E. Coleman, R. W. Bowman, and R. J. Rohrich, “Perioperative corneal abrasion: updated guidelines for prevention and management,” Plastic and Reconstructive Surgery, vol. 137, no. 5, pp. 790e–798e, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Y. Zernii, M. O. Golovastova, V. E. Baksheeva et al., “Alterations in tear biochemistry associated with postanesthetic chronic dry eye syndrome,” Biochemistry (Moscow), vol. 81, no. 12, pp. 1549–1557, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Skalicky, C. Petsoglou, A. Gurbaxani, C. L. Fraser, and P. McCluskey, “New agents for treating dry eye syndrome,” Current Allergy and Asthma Reports, vol. 13, no. 3, pp. 322–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Messmer, “The pathophysiology, diagnosis, and treatment of dry eye disease,” Deutsches Ärzteblatt International, vol. 112, no. 5, pp. 71–81; quiz 82, 2015. View at Publisher · View at Google Scholar
  9. E. Y. Zernii, V. E. Baksheeva, E. V. Yani, P. P. Philippov, and I. I. Senin, “Therapeutic proteins for treatment of corneal epithelial defects,” Current Medicinal Chemistry, vol. 24, 2017. View at Publisher · View at Google Scholar
  10. J. Kruk, K. Kubasik-Kladna, and H. Y. Aboul-Enein, “The role oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physical activity,” Mini Reviews in Medicinal Chemistry, vol. 16, no. 3, pp. 241–257, 2015. View at Publisher · View at Google Scholar
  11. R. K. Crouch, P. Goletz, A. Snyder, and W. H. Coles, “Antioxidant enzymes in human tears,” Journal of Ocular Pharmacology, vol. 7, no. 3, pp. 253–258, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. A. V. Saijyothi, J. Fowjana, S. Madhumathi et al., “Tear fluid small molecular antioxidants profiling shows lowered glutathione in keratoconus,” Experimental Eye Research, vol. 103, pp. 41–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. H. Wakamatsu, M. Dogru, and K. Tsubota, “Tearful relations: oxidative stress, inflammation and eye diseases,” Arquivos Brasileiros de Oftalmologia, vol. 71, 6 Supplement, pp. 72–79, 2008. View at Publisher · View at Google Scholar
  14. A. S. Andrade, T. B. Salomon, C. S. Behling et al., “Alpha-lipoic acid restores tear production in an animal model of dry eye,” Experimental Eye Research, vol. 120, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Higuchi, H. Inoue, Y. Kaneko, E. Oonishi, and K. Tsubota, “Selenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals,” Scientific Reports, vol. 6, p. 36903, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Higuchi, H. Inoue, T. Kawakita, T. Ogishima, and K. Tsubota, “Selenium compound protects corneal epithelium against oxidative stress,” PLoS One, vol. 7, no. 9, article e45612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Higuchi, K. Takahashi, M. Hirashima, T. Kawakita, and K. Tsubota, “Selenoprotein P controls oxidative stress in cornea,” PLoS One, vol. 5, no. 3, article e9911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Hua, R. Deng, J. Li et al., “Protective effects of L-carnitine against oxidative injury by hyperosmolarity in human corneal epithelial cells,” Investigative Ophthalmology & Visual Science, vol. 56, no. 9, pp. 5503–5511, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Li, J. H. Choi, H. J. Oh, S. H. Park, J. B. Lee, and K. C. Yoon, “Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye,” Current Eye Research, vol. 39, no. 9, pp. 871–878, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. V. P. Skulachev, V. N. Anisimov, Y. N. Antonenko et al., “An attempt to prevent senescence: a mitochondrial approach,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1787, no. 5, pp. 437–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Gollihue and A. G. Rabchevsky, “Prospects for therapeutic mitochondrial transplantation,” Mitochondrion, vol. 35, pp. 70–79, 2017. View at Publisher · View at Google Scholar
  22. M. V. Blagosklonny, J. Campisi, D. A. Sinclair et al., “Impact papers on aging in 2009,” Aging, vol. 2, no. 3, pp. 111–121, 2010. View at Publisher · View at Google Scholar
  23. Y. N. Antonenko, A. V. Avetisyan, L. E. Bakeeva et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies,” Biochemistry (Moscow), vol. 73, no. 12, pp. 1273–1287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Zhao, G. Luo, S. Giannelli, and H. H. Szeto, “Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines,” Biochemical Pharmacology, vol. 70, no. 12, pp. 1796–1806, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Smith, C. M. Porteous, C. V. Coulter, and M. P. Murphy, “Selective targeting of an antioxidant to mitochondria,” European Journal of Biochemistry, vol. 263, no. 3, pp. 709–716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. T. A. Ajith and T. G. Jayakumar, “Mitochondria-targeted agents: future perspectives of mitochondrial pharmaceutics in cardiovascular diseases,” World Journal of Cardiology, vol. 6, no. 10, pp. 1091–1099, 2014. View at Publisher · View at Google Scholar
  27. A. Petrov, N. Perekhvatova, M. Skulachev, L. Stein, and G. Ousler, “SkQ1 ophthalmic solution for dry eye treatment: results of a phase 2 safety and efficacy clinical study in the environment and during challenge in the controlled adverse environment model,” Advances in Therapy, vol. 33, no. 1, pp. 96–115, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. V. V. Brzheskiy, E. L. Efimova, T. N. Vorontsova et al., “Results of a multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of Visomitin eye drops in patients with dry eye syndrome,” Advances in Therapy, vol. 32, no. 12, pp. 1263–1279, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. L. E. Bakeeva, C. M. Eldarov, I. M. Vangely, N. G. Kolosova, and V. B. Vays, “Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland,” Oncotarget, vol. 7, no. 49, pp. 80208–80222, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Wipperman and J. N. Dorsch, “Evaluation and management of corneal abrasions,” American Family Physician, vol. 87, no. 2, pp. 114–120, 2013. View at Google Scholar
  31. K. C. Cater and J. W. Harbell, “Prediction of eye irritation potential of liquid and granular laundry detergent formulas using the bovine corneal opacity and permeability (BCOP) assay,” Cutaneous and Ocular Toxicology, vol. 32, no. 3, pp. 210–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. F. R. Notice, Ed., Public Comment Prepared by the Institute for In Vitro Sciences, vol. 69, no. 212, pp. 64081-64082, 2004.
  33. J. A. Kiernan, Histological and Histochemical Methods: Theory and Practice, Scion Publishing, Oxford, 4th edition, 2008.
  34. J. K. Maurer and R. D. Parker, “Light microscopic comparison of surfactant-induced eye irritation in rabbits and rats at three hours and recovery/day 35,” Toxicologic Pathology, vol. 24, no. 4, pp. 403–411, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Y. Zernii, A. A. Nazipova, O. S. Gancharova et al., “Light-induced disulfide dimerization of recoverin under ex vivo and in vivo conditions,” Free Radical Biology & Medicine, vol. 83, pp. 283–295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Bhattacharya, Y. Ning, F. Zhao et al., “Tear production after bilateral main lacrimal gland resection in rabbits,” Investigative Ophthalmology & Visual Science, vol. 56, no. 13, pp. 7774–7783, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. P. D. Gautheron, V. J. Lotti, and J. C. Le Douarec, “Tear film breakup time prolonged with unmedicated cellulose polymer inserts,” Archives of Ophthalmology, vol. 97, no. 10, pp. 1944–1947, 1979. View at Publisher · View at Google Scholar · View at Scopus
  38. O. V. Gulidova, O. B. Liubitskii, G. I. Klebanov, and N. B. Chesnokova, “Changes in the antioxidative activity of tears during experimental eye burns,” Biulleten' Eksperimental'noĭ Biologii i Meditsiny, vol. 128, no. 11, pp. 571–574, 1999. View at Google Scholar
  39. E. Y. Zernii, O. S. Gancharova, I. E. Ishutina et al., “Mechanisms of perioperative corneal abrasions: alterations in tear film proteome,” Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, vol. 11, no. 2, pp. 186–193, 2017. View at Publisher · View at Google Scholar
  40. I. G. Sommers, “Chapter IV - general pathology in relation to the eye,” in Histology and Histopathology of the Eye and its Adnexa, pp. 57–129, Butterworth-Heinemann, Oxford, UK, 2013. View at Google Scholar
  41. C. T. Lai, W. C. Yao, S. Y. Lin et al., “Changes of ocular surface and the inflammatory response in a rabbit model of short-term exposure keratopathy,” PLoS One, vol. 10, no. 9, article e0137186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Y. Zernii, V. E. Baksheeva, E. N. Iomdina et al., “Rabbit models of ocular diseases: new relevance for classical approaches,” CNS & Neurological Disorders Drug Targets, vol. 15, no. 3, pp. 267–291, 2016. View at Publisher · View at Google Scholar
  43. E. White and M. M. Crosse, “The aetiology and prevention of peri-operative corneal abrasions,” Anaesthesia, vol. 53, no. 2, pp. 157–161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Hua and T. Doll, “A series of 3 cases of corneal abrasion with multiple etiologies,” Optometry, vol. 81, no. 2, pp. 83–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. K. Batra and I. M. Bali, “Corneal abrasions during general anesthesia,” Anesthesia and Analgesia, vol. 56, no. 3, pp. 363–365, 1977. View at Publisher · View at Google Scholar
  46. D. Munro and J. R. Treberg, “A radical shift in perspective: mitochondria as regulators of reactive oxygen species,” The Journal of Experimental Biology, vol. 220, Part 7, pp. 1170–1180, 2017. View at Publisher · View at Google Scholar
  47. E. N. Iomdina, I. P. Khoroshilova-Maslova, O. V. Robustova et al., “Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits,” Frontiers in Bioscience (Landmark Edition), vol. 20, pp. 892–901, 2015. View at Publisher · View at Google Scholar
  48. V. P. Skulachev, “Cationic antioxidants as a powerful tool against mitochondrial oxidative stress,” Biochemical and Biophysical Research Communications, vol. 441, no. 2, pp. 275–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. V. V. Neroev, M. M. Archipova, L. E. Bakeeva et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals,” Biochemistry (Moscow), vol. 73, no. 12, pp. 1317–1328, 2008. View at Google Scholar
  50. G. Fouret, E. Tolika, J. Lecomte et al., “The mitochondrial-targeted antioxidant, MitoQ, increases liver mitochondrial cardiolipin content in obesogenic diet-fed rats,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1847, no. 10, pp. 1025–1035, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. V. P. Skulachev, Y. N. Antonenko, D. A. Cherepanov et al., “Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs),” Elsevier Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1797, no. 6-7, pp. 878–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. S. Jankauskas, E. Y. Plotnikov, M. A. Morosanova et al., “Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss,” Biochemistry (Moscow), vol. 77, no. 6, pp. 666–670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. L. E. Bakeeva, I. V. Barskov, M. V. Egorov et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke),” Biochemistry (Moscow), vol. 73, no. 12, pp. 1288–1299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. N. A. Stefanova, N. A. Muraleva, V. P. Skulachev, and N. G. Kolosova, “Alzheimer’s disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1,” Journal of Alzheimer's Disease, vol. 38, no. 3, pp. 681–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. V. B. Saprunova, M. A. Lelekova, N. G. Kolosova, and L. E. Bakeeva, “SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of Wistar and OXYS rats,” Biochemistry (Moscow), vol. 77, no. 6, pp. 648–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. V. P. Skulachev, “Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases,” Journal of Alzheimer's Disease, vol. 28, no. 2, pp. 283–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. U. M. Sarmiento, J. I. Sarmiento, and R. Storb, “Allelic variation in the DR subregion of the canine major histocompatibility complex,” Immunogenetics, vol. 32, no. 1, pp. 13–19, 1990. View at Google Scholar
  58. Y. Chen, G. Mehta, and V. Vasiliou, “Antioxidant defenses in the ocular surface,” The Ocular Surface, vol. 7, no. 4, pp. 176–185, 2009. View at Publisher · View at Google Scholar
  59. J. Cejkova, S. Stipek, J. Crkovska et al., “UV rays, the prooxidant/antioxidant imbalance in the cornea and oxidative eye damage,” Physiological Research, vol. 53, no. 1, pp. 1–10, 2004. View at Google Scholar
  60. R. Brigelius-Flohe, “Glutathione peroxidases and redox-regulated transcription factors,” Biological Chemistry, vol. 387, no. 10-11, pp. 1329–1335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Kovaceva, J. Platenik, M. Vejrazka et al., “Differences in activities of antioxidant superoxide dismutase, glutathione peroxidase and prooxidant xanthine oxidoreductase/xanthine oxidase in the normal corneal epithelium of various mammals,” Physiological Research, vol. 56, no. 1, pp. 105–112, 2007. View at Google Scholar
  62. A. Behndig, K. Karlsson, B. O. Johansson, T. Brannstrom, and S. L. Marklund, “Superoxide dismutase isoenzymes in the normal and diseased human cornea,” Investigative Ophthalmology & Visual Science, vol. 42, no. 10, pp. 2293–2296, 2001. View at Google Scholar
  63. I. Fridovich, “Superoxide radical and superoxide dismutases,” Annual Review of Biochemistry, vol. 64, pp. 97–112, 1995. View at Publisher · View at Google Scholar
  64. I. Escribano-Lopez, N. Diaz-Morales, S. Rovira-Llopis et al., “The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients,” Redox Biology, vol. 10, pp. 200–205, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. M. S. Milner, K. A. Beckman, J. I. Luchs et al., “Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment,” Current Opinion in Ophthalmology, vol. 27, Supplement 1, pp. 3–47, 2017. View at Publisher · View at Google Scholar
  66. H. Toshida, D. H. Nguyen, R. W. Beuerman, and A. Murakami, “Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit,” Investigative Ophthalmology & Visual Science, vol. 48, no. 10, pp. 4468–4475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. S. A. Aicher, S. M. Hermes, and D. M. Hegarty, “Denervation of the lacrimal gland leads to corneal hypoalgesia in a novel rat model of aqueous dry eye disease,” Investigative Ophthalmology & Visual Science, vol. 56, no. 11, pp. 6981–6989, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. K. C. Bhuyan and D. K. Bhuyan, “Regulation of hydrogen peroxide in eye humors. Effect of 3-amino-1H-1,2,4-triazole on catalase and glutathione peroxidase of rabbit eye,” Elsevier Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 497, no. 3, pp. 641–651, 1977. View at Google Scholar
  69. M. V. Riley, “A role for glutathione and glutathione reductase in control of corneal hydration,” Experimental Eye Research, vol. 39, no. 6, pp. 751–758, 1984. View at Publisher · View at Google Scholar · View at Scopus
  70. A. N. Lukashev, M. V. Skulachev, V. Ostapenko, A. Y. Savchenko, V. V. Pavshintsev, and V. P. Skulachev, “Advances in development of rechargeable mitochondrial antioxidants,” Progress in Molecular Biology and Translational Science, vol. 127, pp. 251–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Daheshia, N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse, “Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10,” Journal of Immunology, vol. 159, no. 4, pp. 1945–1952, 1997. View at Google Scholar
  72. R. de Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes,” The Journal of Experimental Medicine, vol. 174, no. 5, pp. 1209–1220, 1991. View at Publisher · View at Google Scholar
  73. E. W. Lindstedt, G. S. Baarsma, R. W. Kuijpers, and P. M. van Hagen, “Anti-TNF-α therapy for sight threatening uveitis,” The British Journal of Ophthalmology, vol. 89, no. 5, pp. 533–536, 2005. View at Publisher · View at Google Scholar · View at Scopus